FDAnews
www.fdanews.com/articles/108352-york-pharma-acquires-anti-infective-topical-derm-line-from-solvay

York Pharma Acquires Anti-Infective Topical Derm Line From Solvay

July 8, 2008
York Pharma has announced the acquisition of the sales and worldwide commercial rights to two dermatological products from the Belgian Pharmaceutical and Chemical Company Solvay for a total consideration of €28.5m.
Objective Capital